Cinco de Mayo Earnings Report

Discussion in 'Merck' started by anonymous, May 3, 2016 at 3:10 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    What are your predictions for Thursday morning? Will Wall Street be pleased or disappointed with our 1st Qtr performance?
     

  2. anonymous

    anonymous Guest

    I'm sure they will be impressed with our pneumoconjugate vaccine results vs. Prevnar.

    Oh, wait ...
     
  3. anonymous

    anonymous Guest

    1q 2016 will be okay. Sales up but revenue down. The key will be 1q of 2017 and see how much of the revenue will be lost from the diabetes franchise. Thank goodness for keytruda and zeptier! Vaccines will do well too!
     
  4. anonymous

    anonymous Guest

    Wall Street is prepared for a huge surge, stock may hit 85$ per share Thursday. Why? Our 1q Zontivity sales are off the charts, epic sales trend. I believe we broke the 1 million dollar mark. Bahaaaa ahhaaaaa.
     
  5. anonymous

    anonymous Guest

    Surprise to the downside. You've been warned. Sell now
     
  6. anonymous

    anonymous Guest

    Get this Mexican shit off our site
     
  7. anonymous

    anonymous Guest

    Wall Street will be pleased. With the never-ending cost reductions, we should have decent earnings.

    The smart analysts, however, will see the downward spiral for what it is. This company is train wreck, top to bottom.
     
  8. anonymous

    anonymous Guest

    Sales for diabetes franchise will disappoint. Declining revenue for mature products will disappoint. Hepatitis and Oncology sales will have to save the day.
     
  9. anonymous

    anonymous Guest

    More Red than Green :(
     
  10. anonymous

    anonymous Guest


    Yeah... What's up beaner?
     
  11. anonymous

    anonymous Guest



    What do you say now dick ass? Looks like you've bern exposed for the moron you've always been
     
  12. anonymous

    anonymous Guest


    Looks pretty Red on a day that is Green for the market. Not good. Not good at all.
     
  13. anonymous

    anonymous Guest

    I say stock currently down -1.7%, as I predicted. A Cleveland Steamer on your face little novice.
     
  14. anonymous

    anonymous Guest

    If it wasn't for the dividend, there there would be no reason to hold this stock. There are too many threats to Merck's products in every therapy area.
     
  15. anonymous

    anonymous Guest

    If it wasn't for the dividend, there there would be no reason to hold this stock. There are too many threats to Merck's products in every therapy area.
     
  16. anonymous

    anonymous Guest

    Quite trying to complicate the report. The company was above all projections. Simple. Get it right Mr. MBA
     
  17. anonymous

    anonymous Guest


    Hey rookie..you looking at stock price for one day? Yeah, well, the financial report takes in to account the long term figures. I'll explain it to you sometime grasshopper. You look at one day, I'll look at the long term you moron. Unbelievable.
     
  18. anonymous

    anonymous Guest

  19. anonymous

    anonymous Guest

  20. anonymous

    anonymous Guest

    You got me on that one

    I also didn't like reading we beat analyst predictions by only increasing keytruda sales and cost cutting.

    And then the CEO cashes in with 24 million